MARKET

VSTM

VSTM

Verastem
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.900
-0.070
-3.55%
After Hours: 1.900 0 0.00% 17:40 01/17 EST
OPEN
1.980
PREV CLOSE
1.970
HIGH
2.030
LOW
1.850
VOLUME
1.37M
TURNOVER
--
52 WEEK HIGH
3.685
52 WEEK LOW
0.8300
MARKET CAP
141.26M
P/E (TTM)
-1.1370
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VSTM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VSTM News

  • Verastem In-Licenses KRAS-Focused Drug From Chugai, Stock Up
  • Zacks.01/09 14:00
  • VSTM, PIR, ADMS and ITCI among midday movers
  • Seeking Alpha - Article.01/08 17:44
  • TRXC, VSTM among premarket gainers
  • Seeking Alpha - Article.01/08 14:16
  • The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results
  • Benzinga.01/08 13:12

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About VSTM

Verastem, Inc., is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. It is also developing a dual inhibitor of PI3K-delta and PI3K-gamma, which has completed Phase 2 study in indolent non-hodgkin lymphoma. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and mesothelioma.
More

Webull offers Verastem Inc (VSTM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.